LncRNA MIR205HG Drives Esophageal Squamous Cell Carcinoma Progression by Regulating miR-214/SOX4 Axis

Background Esophageal squamous cell carcinoma (ESCC) is a common and fatal malignancy, which has posed a great challenge to public health, especially in China. Dysregulation of long non-coding RNAs is involved in the occurrence, development, invasion, and metastasis of multiple cancers including ESCC. However, little is known about the function of MIR205HG in ESCC. Methods We used qRT-PCR to detect the expression level of MIR205HG, miR-214, and SOX4 in human ESCC tissues and cell lines. Loss-of-functional assays were performed to test the impact of MIR205HG on cell proliferation, metastasis, and apoptosis process via CCK-8, transwell, and flow cell cytometry assays. Additionally, the downstream molecular mechanism of MIR205HG in ESCC was explored. Results Here, we found MIR205HG was substantially up-regulated in ESCC, and there was a positive correlation between MIR205HG expression and tumor size and lymphatic metastasis of ESCC patients. Inhibition of MIR205HG attenuated cell proliferation, migration, and invasion. Silencing MIR205HG increased G1 phase cell counts and decreased S phase cell counts, along with increased apoptotic cell populations. Notably, the rescue assays indicated that miR-214 could partly reverse the influence of MIR205HG on ESCC cell migration. We also found that SOX4 was a direct target mRNA of miR-214, and MIR205HG could act as a molecular sponge to regulate SOX4 expression in ESCC. Conclusion Taken together, our findings demonstrate that MIR205HG promotes ESCC progression by regulating the miR-214/SOX4 axis. MIR205HG may be a novel candidate target for ESCC diagnosis and therapy.

[1]  Qiong Yang,et al.  Long Non-Coding RNA LINC01089 Enhances the Development of Gastric Cancer by Sponging miR-145-5p to Mediate SOX9 Expression , 2020, OncoTargets and therapy.

[2]  Qunbang Chen,et al.  lncRNA CRNDE is Upregulated in Glioblastoma Multiforme and Facilitates Cancer Progression Through Targeting miR-337-3p and ELMOD2 Axis , 2020, OncoTargets and therapy.

[3]  Juan Zhao,et al.  LncRNA TTN-AS1 promotes the progression of oral squamous cell carcinoma via miR-411-3p/NFAT5 axis , 2020, Cancer Cell International.

[4]  Xiaofeng Chen,et al.  POLE2 knockdown reduce tumorigenesis in esophageal squamous cells , 2020, Cancer Cell International.

[5]  Chunhui Cao,et al.  Long non-coding RNA SNHG6 regulates the sensitivity of prostate cancer cells to paclitaxel by sponging miR-186 , 2020, Cancer Cell International.

[6]  Limin Liu,et al.  MIR205HG acts as a ceRNA to expedite cell proliferation and progression in lung squamous cell carcinoma via targeting miR-299-3p/MAP3K2 axis , 2020, BMC Pulmonary Medicine.

[7]  Liang’an Chen,et al.  MIR205HG facilitates carcinogenesis of lung squamous cell carcinoma in vitro revealed by long noncoding RNA profiling. , 2020, Acta biochimica et biophysica Sinica.

[8]  Li Sun,et al.  lncRNA SNHG3 acts as a novel Tumor Suppressor and regulates Tumor Proliferation and Metastasis via AKT/mTOR/ERK pathway in Papillary Thyroid Carcinoma , 2020, Journal of Cancer.

[9]  Jialong Liang,et al.  Inter- and intratumor DNA methylation heterogeneity associated with lymph node metastasis and prognosis of esophageal squamous cell carcinoma , 2020, Theranostics.

[10]  Hongxiang Chen,et al.  Comprehensive Analysis of a Competing Endogenous RNA Network Identifies Seven-lncRNA Signature as a Prognostic Biomarker for Melanoma , 2019, Front. Oncol..

[11]  R. Kelly Emerging Multimodality Approaches to Treat Localized Esophageal Cancer. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

[12]  F. He,et al.  LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[13]  A. Guo,et al.  GEDS: A Gene Expression Display Server for mRNAs, miRNAs and Proteins , 2019, Cells.

[14]  F. Zhou,et al.  Decreased expression of SPINT1-AS1 and SPINT1 mRNA might be independent unfavorable prognostic indicators in esophageal squamous cell carcinoma , 2019, OncoTargets and therapy.

[15]  Hongying Wang,et al.  Long non-coding RNA MIR205HG function as a ceRNA to accelerate tumor growth and progression via sponging miR-122-5p in cervical cancer. , 2019, Biochemical and biophysical research communications.

[16]  F. He,et al.  Long noncoding RNA FEZF1-AS1 promotes the motility of esophageal squamous cell carcinoma through Wnt/β-catenin pathway , 2019, Cancer management and research.

[17]  Juan Li,et al.  Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer , 2019, Molecular Cancer.

[18]  Zhixiang Zuo,et al.  lnCAR: A Comprehensive Resource for lncRNAs from Cancer Arrays. , 2019, Cancer research.

[19]  Jun Liu,et al.  JMJD6 promotes hepatocellular carcinoma carcinogenesis by targeting CDK4 , 2018, International journal of cancer.

[20]  J. Liu,et al.  HOXB9 promotes endometrial cancer progression by targeting E2F3 , 2018, Cell Death & Disease.

[21]  Andrea Sacconi,et al.  Long Non-coding MIR205HG Depletes Hsa-miR-590-3p Leading to Unrestrained Proliferation in Head and Neck Squamous Cell Carcinoma , 2018, Theranostics.

[22]  Liang Wang,et al.  MiR-214 inhibits the proliferation and invasion of esophageal squamous cell carcinoma cells by targeting CDC25B. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[23]  Yanping Zhang,et al.  HNF1A-AS1 promotes growth and metastasis of esophageal squamous cell carcinoma by sponging miR-214 to upregulate the expression of SOX-4 , 2017, International journal of oncology.

[24]  Zhihua Yin,et al.  Diagnostic value of long non-coding RNA H19, UCA1, and HOTAIR as promising biomarkers in human bladder cancer. , 2017, International journal of clinical and experimental pathology.

[25]  C. Andl,et al.  SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells , 2015, Molecular Cancer.

[26]  Yang Yuan,et al.  MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma , 2012, Molecular Cancer.